NCT01564784 2019-01-09
A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Pfizer
Phase 3 Completed
Clinical Trials
1 trialsHas announcements × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Granulocyte Colony-Stimulating Factor × Clear all